Showing results (131-140 of 144) with videos related to
Sort By:
Pageof 15
Ecancermedicalscience|October 6, 2023
The current status of geriatric oncology in IndiaVanita Noronha, Abhijith Rajaram Rao, Anant Ramaswamy, et al.Ecancermedicalscience|October 18, 2024
Predictive significance of inflammatory markers in the survival of older Indian patients with cancer: a single-center prospective analysisAbhijith Rajaram Rao, Vanita Noronha, Anant Ramaswamy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2017
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority TrialVanita Noronha, Amit Joshi, Vijay Maruti Patil, et al.Journal of Geriatric Oncology|March 1, 2024
Assessing frailty in older Indian patients before cancer treatment: Comparative analysis of three scales and their implications for overall survivalAbhijith R Rao, Vanita Noronha, Anant Ramaswamy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2026
Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII)Vanita Noronha, Vijay Patil, Nandini Menon, et al.Cancer Medicine|October 31, 2020
COVID-19 in cancer patients on active systemic therapy - Outcomes from LMIC scenario with an emphasis on need for active treatmentAnant Ramaswamy, Lingaraj Nayak, Nirmalya Roy Moulik, et al.JCO Global Oncology|May 22, 2025
Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study)Akhil Kapoor, Anuj Gupta, Bipinesh Sansar, et al.The Lancet. Haematology|March 16, 2025
Talicabtagene autoleucel for relapsed or refractory B-cell malignancies: results from an open-label, multicentre, phase 1/2 studyHasmukh Jain, Atharva Karulkar, Devanshi Kalra, et al.BMJ Oncology|January 31, 2025
Under-representation of older Indian persons with cancer in clinical trialsVanita Noronha, Vijay Patil, Nandini Menon, et al.The Lancet. Global Health|August 23, 2020
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trialVijay Patil, Vanita Noronha, Sachin Babanrao Dhumal, et al.Pageof 15